BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 22370380)

  • 21. Perceived successes and challenges of clinical pharmacist practitioners in North Carolina.
    Hale JC; Murawski MM; Ives TJ
    J Am Pharm Assoc (2003); 2013; 53(6):640-3. PubMed ID: 24185431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrospective analysis of billing at a standalone medication therapy management clinic.
    Hager KD; Gosser RA
    Am J Health Syst Pharm; 2016 Jan; 73(2):77-81. PubMed ID: 26721537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of reimbursement in a community hospital-based pharmacist-managed outpatient transition clinic.
    Huang J; Tattersall R; Morse K; Nickerson-Troy J; Clements E; Celauro L; Lovell A
    Am J Health Syst Pharm; 2017 Jun; 74(11 Supplement 2):S30-S34. PubMed ID: 28506974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of pharmacist-provided Medicare annual wellness visits and chronic care management on reimbursement and quality measures in a privately owned family medicine clinic.
    Mack K; Henneman A; Snyder T
    Am J Health Syst Pharm; 2023 Nov; 80(Suppl 4):S143-S150. PubMed ID: 36860179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacists' acceptable levels of compensation for MTM services: a conjoint analysis.
    Wang J; Hong SH; Meng S; Brown LM
    Res Social Adm Pharm; 2011 Dec; 7(4):383-95. PubMed ID: 21272533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacist-provided immunization compensation and recognition: white paper summarizing APhA/AMCP stakeholder meeting.
    Skelton JB; ;
    J Am Pharm Assoc (2003); 2011; 51(6):704-12. PubMed ID: 22068191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ReCAP: Pharmacists' Impact in Hematopoietic Stem-Cell Transplantation: Economic and Humanistic Outcomes.
    Alexander MD; Rao KV; Khan TS; Deal AM; Alexander MD; Rao KV; Khan TS; Deal AM
    J Oncol Pract; 2016 Feb; 12(2):147-8, e118-26. PubMed ID: 26787757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mapping the route to medication therapy management documentation and billing standardization and interoperabilility within the health care system: meeting proceedings.
    Millonig MK
    J Am Pharm Assoc (2003); 2009; 49(3):372-82. PubMed ID: 19357067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of anticoagulation care in patients discharged from a pharmacist-managed anticoagulation clinic after stabilization of warfarin therapy.
    Garwood CL; Dumo P; Baringhaus SN; Laban KM
    Pharmacotherapy; 2008 Jan; 28(1):20-6. PubMed ID: 18154470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of prescription reimbursement methodologies in Japan and the United States.
    Akaho E; MacLaughlin EJ; Takeuchi Y
    J Am Pharm Assoc (2003); 2003; 43(4):519-26. PubMed ID: 12952317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Provision of pharmaceutical care services in North Carolina: a 1999 survey.
    McDermott JH; Christensen DB
    J Am Pharm Assoc (Wash); 2002; 42(1):26-35. PubMed ID: 11833512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. National billing codes announced for pharmacists' clinical services.
    Thompson CA
    Am J Health Syst Pharm; 2005 Aug; 62(16):1640-2. PubMed ID: 16085922
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluation of a pilot medication therapy management project within the North Carolina State Health Plan.
    Christensen DB; Roth M; Trygstad T; Byrd J
    J Am Pharm Assoc (2003); 2007; 47(4):471-83. PubMed ID: 17616493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Description of the characteristics of pharmacist-based immunization services in North Carolina: results of a pharmacist survey.
    Kummer GL; Foushee LL
    J Am Pharm Assoc (2003); 2008; 48(6):744-51. PubMed ID: 19019803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incident-to Billing for Pharmacists.
    Dietrich E; Gums JG
    J Manag Care Spec Pharm; 2018 Dec; 24(12):1273-1276. PubMed ID: 30479200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of two different models of anticoagulation management services with usual medical care.
    Rudd KM; Dier JG
    Pharmacotherapy; 2010 Apr; 30(4):330-8. PubMed ID: 20334453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes-based pharmacist reimbursement: reimbursing pharmacists for cognitive services part 1.
    Farris KB; Kumbera P; Halterman T; Fang G
    J Manag Care Pharm; 2002; 8(5):383-93. PubMed ID: 14613406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advanced Practice Pharmacists: a retrospective evaluation of the efficacy and cost of ClinicaL Pharmacist PractitionErs managing ambulatory Medicare patients in North Carolina (APPLE-NC).
    Kislan MM; Bernstein AT; Fearrington LR; Ives TJ
    BMC Health Serv Res; 2016 Oct; 16(1):607. PubMed ID: 27769219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reimbursement and costs of pediatric ambulatory diabetes care by using the resource-based relative value scale: is multidisciplinary care financially viable?
    Melzer SM; Richards GE; Covington ML
    Pediatr Diabetes; 2004 Sep; 5(3):133-42. PubMed ID: 15450008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Billing for cognitive services: understanding Québec pharmacists' behavior.
    Kröger E; Moisan J; Grégoire JP
    Ann Pharmacother; 2000 Mar; 34(3):309-16. PubMed ID: 10917375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.